The future of cancer screening after COVID-19 may be at home

Sherri N Sheinfeld Gorin; Masahito Jimbo; Robert Heizelman; Kathryn M Harmes; Diane M Harper

doi:10.1002/cncr.33274

The future of cancer screening after COVID-19 may be at home

Cancer. 2021 Feb 15;127(4):498-503. doi: 10.1002/cncr.33274. Epub 2020 Nov 10.

Authors

Sherri N Sheinfeld Gorin¹, Masahito Jimbo¹, Robert Heizelman¹, Kathryn M Harmes¹, Diane M Harper^{1

2

3

4}

Affiliations

¹ Department of Family Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan.
² Department of Obstetrics and Gynecology, University of Michigan School of Medicine, Ann Arbor, Michigan.
³ Department of Women's Studies, College of Literature, Science, and the Arts, University of Michigan, Ann Arbor, Michigan.
⁴ Hub Research Capacity Core, Michigan Institute for Clinical and Health Research, University of Michigan, Ann Arbor, Michigan.

PMID: 33170520
DOI: 10.1002/cncr.33274

Abstract

During the coronavirus disease 2019 (COVID-19) pandemic, cancer screening decreased precipitously; home screening for colorectal cancer diminished less than that for colonoscopy and breast and cervical cancer screening. The authors have highlighted approaches for home cancer screening in addition to telemedicine.

Keywords: COVID-19; breast; cancer; cervical; colorectal; home; screening.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 / epidemiology*
COVID-19 / virology
Early Detection of Cancer / methods*
Early Detection of Cancer / trends*
Humans
Michigan / epidemiology
SARS-CoV-2 / isolation & purification
Telemedicine / methods*

Grants and funding

University of Michigan School of Medicine